{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:31:03Z","timestamp":1790429463846,"version":"4.1.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1093\/neuonc\/nos288","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T01:33:13Z","timestamp":1355275993000},"page":"216-223","source":"Crossref","is-referenced-by-count":64,"title":["Levetiracetam improves verbal memory in high-grade glioma patients"],"prefix":"10.1093","volume":"15","author":[{"given":"Marjolein","family":"de Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Douw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eefje M.","family":"Sizoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Bosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke E.","family":"Froklage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Heimans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjeerd J.","family":"Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap C.","family":"Reijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,12,11]]},"reference":[{"key":"key\n\t\t\t\t20170511101222_NOS288C1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3171\/2008.4.17536","article-title":"Independent association of extent of resection with survival in patients with malignant brain astrocytoma","volume":"110","author":"McGirt","year":"2009","journal-title":"J Neurosurg"},{"key":"key\n\t\t\t\t20170511101222_NOS288C2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1474-4422(07)70103-5","article-title":"Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management","volume":"6","author":"van Breemen","year":"2007","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/CCO.0b013e32833de99d","article-title":"Epilepsy and brain tumors","volume":"22","author":"Rud\u00e0","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"Pt 4","key":"key\n\t\t\t\t20170511101222_NOS288C4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/brain\/awr310","article-title":"Epilepsy in patients with a brain tumour: focal epilepsy requires focused treatment","volume":"135","author":"De Groot","year":"2012","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170511101222_NOS288C5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11065-007-9043-9","article-title":"Neuropsychological and behavioral effects of antiepilepsy drugs","volume":"17","author":"Loring","year":"2007","journal-title":"Neuropsychol Rev"},{"key":"key\n\t\t\t\t20170511101222_NOS288C6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1755-5949.2008.00062.x","article-title":"The aspects and mechanisms of cognitive alterations in epilepsy: the role of antiepileptic medications","volume":"15","author":"Hamed","year":"2009","journal-title":"CNS Neurosci Ther"},{"key":"key\n\t\t\t\t20170511101222_NOS288C7","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1212\/WNL.58.8_suppl_5.S21","article-title":"Cognitive outcomes and predictive factors in epilepsy","volume":"58","author":"Meador","year":"2002","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170511101222_NOS288C8","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2001.19.20.4037","article-title":"Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients","volume":"19","author":"Klein","year":"2001","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1215\/15228517-2006-012","article-title":"The course of neurocognitive functioning in high-grade glioma patients","volume":"9","author":"Bosma","year":"2007","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S1474-4422(09)70204-2","article-title":"Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up","volume":"8","author":"Douw","year":"2009","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.10712","article-title":"Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life","volume":"54","author":"Klein","year":"2003","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eplepsyres.2005.10.006","article-title":"Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy","volume":"68","author":"Piazzini","year":"2006","journal-title":"Epilepsy Res"},{"key":"key\n\t\t\t\t20170511101222_NOS288C13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.yebeh.2008.07.012","article-title":"The effects of levetiracetam on cognition: a non-interventional surveillance study","volume":"13","author":"Helmstaedter","year":"2008","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t20170511101222_NOS288C14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yebeh.2009.08.026","article-title":"Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study","volume":"16","author":"Wu","year":"2009","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t20170511101222_NOS288C15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.yebeh.2007.10.003","article-title":"Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures","volume":"12","author":"Zhou","year":"2008","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t20170511101222_NOS288C16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11060-009-9993-2","article-title":"Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings","volume":"97","author":"Hilverda","year":"2010","journal-title":"J Neurooncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","article-title":"The use of nitrogen mustards in the palliative treatment of carcinoma","volume":"1","author":"Karnofsky","year":"1948","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170511101222_NOS288C18","first-page":"120","article-title":"[The Maastricht aging study (MAAS). The longitudinal perspective of cognitive aging]","volume":"29","author":"Jolles","year":"1998","journal-title":"Tijdschr Gerontol Geriatr"},{"key":"key\n\t\t\t\t20170511101222_NOS288C19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11060-010-0460-x","article-title":"Levetiracetam monotherapy in patients with brain tumor\u2013related epilepsy: seizure control, safety, and quality of life","volume":"104","author":"Maschio","year":"2011","journal-title":"J Neurooncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1200\/JCO.2004.99.290","article-title":"The measurement of cognitive functioning in low-grade glioma patients after radiotherapy","volume":"22","author":"Klein","year":"2004","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C21","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/epd.2008.0227","article-title":"Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study","volume":"10","author":"Lopez-Gongora","year":"2008","journal-title":"Epileptic Disord"},{"key":"key\n\t\t\t\t20170511101222_NOS288C22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1528-1167.2010.02746.x","article-title":"Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam","volume":"52","author":"Meador","year":"2011","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20170511101222_NOS288C23","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1212\/01.wnl.0000281104.55418.60","article-title":"Neuropsychological and neurophysiologic effects of carbamazepine and levetiracetam","volume":"69","author":"Meador","year":"2007","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170511101222_NOS288C24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.yebeh.2010.02.011","article-title":"Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: a non-interventional surveillance trial","volume":"18","author":"Helmstaedter","year":"2010","journal-title":"Epilepsy Behav"},{"key":"key\n\t\t\t\t20170511101222_NOS288C25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yebeh.2007.02.007","article-title":"The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate","volume":"10","author":"Gomer","year":"2007","journal-title":"Epilepsy Behav"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170511101222_NOS288C26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1528-1167.2006.00683.x","article-title":"The effect of antiepileptic drugs on cognition: patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice","volume":"47","author":"Bootsma","year":"2006","journal-title":"Epilepsia"},{"key":"key\n\t\t\t\t20170511101222_NOS288C27","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1440-1819.2008.01848.x","article-title":"Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy","volume":"62","author":"Huang","year":"2008","journal-title":"Psychiatry Clin.Neurosci"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20170511101222_NOS288C28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1528-1157.44.s4.3.x","article-title":"Newer antiepileptic drugs and cognitive issues","volume":"44","author":"Aldenkamp","year":"2003","journal-title":"Epilepsia"},{"issue":"11","key":"key\n\t\t\t\t20170511101222_NOS288C29","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1345\/aph.1E136","article-title":"Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers","volume":"38","author":"Mecarelli","year":"2004","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20170511101222_NOS288C30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10143-009-0191-7","article-title":"Brain tumors and epilepsy: pathophysiology of peritumoral changes","volume":"32","author":"Shamji","year":"2009","journal-title":"Neurosurg Rev"},{"key":"key\n\t\t\t\t20170511101222_NOS288C31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/S0896-6273(00)81046-6","article-title":"SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release","volume":"24","author":"Janz","year":"1999","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170511101222_NOS288C32","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/neuonc\/noq044","article-title":"Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide","volume":"12","author":"Bobustuc","year":"2010","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t20170511101222_NOS288C33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","article-title":"Astrocyte-neuron lactate transport is required for long-term memory formation","volume":"144","author":"Suzuki","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170511101222_NOS288C34","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1212\/01.WNL.0000032104.06944.CD","article-title":"Improvement of a patient with stuttering on levetiracetam","volume":"59","author":"Paola","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"key\n\t\t\t\t20170511101222_NOS288C35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"8","key":"key\n\t\t\t\t20170511101222_NOS288C36","first-page":"627","article-title":"The efficacy and safety of newer anticonvulsants in patients with dementia","volume":"29","author":"Dolder","year":"2012","journal-title":"Drugs Aging"},{"issue":"8","key":"key\n\t\t\t\t20170511101222_NOS288C37","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.39.8.1009","article-title":"Level off","volume":"39","author":"Dodson","year":"1989","journal-title":"Neurology"},{"issue":"4","key":"key\n\t\t\t\t20170511101222_NOS288C38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1528-1157.1993.tb00430.x","article-title":"Guidelines for therapeutic monitoring on antiepileptic drugs.","volume":"34","author":"Commission on Antiepileptic Drugs, International League Against Epilepsy","year":"1993","journal-title":"Epilepsia"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/15\/2\/216\/12792607\/nos288.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T04:53:40Z","timestamp":1714712020000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-lookup\/doi\/10.1093\/neuonc\/nos288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,11]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,11]]},"published-print":{"date-parts":[[2013,2]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/nos288","relation":{},"ISSN":["1523-5866","1522-8517"],"issn-type":[{"value":"1523-5866","type":"electronic"},{"value":"1522-8517","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12,11]]}}}